StemCell Therapy

Stems cell therapy is a cutting-edge technology that is now widely being used in orthopedic and sports medicine. The procedure involves using a patients own stem cells, which have the unique property of being able to develop into many different cell types, to treat injuries and arthritis.

Stem cells can be found in our bone marrow, fat cells and other tissues. These cells are frequently taken from the bone marrow or from a small amount of fat tissue, where a high concentration of stem cells can be extracted. This concentration is known as bone marrow aspirate or lipoaspirate respectively.

The aspirate is then injected into the site of injury so the cells can help repair the injured or degenerative tissue. Stem cell therapy is also commonly used to treat arthritis, meniscal tears and a variety of orthopedic and medical conditions. Patients can experience significant pain relief within one to two months after the procedure.

Although stem cell therapy has been used for decades, it is still considered experimental in orthopedic and sports medicine. Stem cell therapy should not be used as the first step in treating an orthopedic injury.

In addition, the risk of bone marrow aspiration for stem cell therapy includes infection, prolonged bleeding, pain at the aspiration or injection site, bruising and nerve injury.

The best way to determine if you are a candidate for stem cell therapy is to have a thorough evaluation by a physician experienced with stem cell therapies. Stem cell therapy is usually not covered by insurance. However, depending on the type of treatment that is needed, partial reimbursement may be possible.

Dr. Alicia Carter is respected in her field for her experience, personal care, and non-operative approach to orthopedic and sports injuries. As a clinical instructor at Columbia University College of Physicians and Surgeons, she is tasked with staying on the forefront of new technologies that are impacting and improving peoples lives. Dr. Carter has almost a decade of experience in the field of regenerative medicine and she is an active member of the International Society of Regenerative Medicine. Patients prefer her patience, her gentle hand and her anesthetizing techniques, which allow her to perform procedures with minimal or no discomfort. She has successfully treated patients with stem cell therapy and will work with you to determine if its right for you.

Dr. Carter offers complimentary monthly group stem cell therapy information sessions. These sessions do fill quickly so contact our office to reserve your spot today.

Book Now!

Q: Does Dr. Carter perform stem cell treatments for the spine (cervical, thoracic and lumbar) and joints? A: Yes. Dr. Carter treats virtually all orthopedic and sports conditions and can use stem cell treatments for most, including disorders and injuries of the cervical spine.

Q: Where does Dr. Carter get the stem cells from?A: Stem cells can be obtained from the bone marrow/pelvic bone or from a small amount of abdominal fat tissue.

Q: Is stem cell therapy covered by insurance? A: Stem cell therapy is typically not covered by insurances. However, depending on your condition, partial reimbursement may be possible. Reimbursement questions can be answered in more detail after your consult and once we know more about your insurance coverage.

Q: How much does stem cell therapy cost?A: The price can vary depending on the type of condition being treated and whether bone marrow aspirate or fat tissue is utilized to acquire the stem cells.

Q: Do I have to pay for the initial consult? A: It depends on your insurance plan. If you have to pay upfront for initial consult, then it will be deducted from the total cost of the stem cell procedure if you are a candidate. If youre not a candidate, then the consultation feet is nonrefundable however, alternative treatments will be thoroughly discussed. We will gladly submit the consult visit claim to your insurance company on your behalf, which may or may not be reimbursable.

Originally posted here:
Stem Cell Therapy For Orthopedic Injuries and Arthritis ...

Palliative management has consisted of lifestyle changes (diet, exercise, activity restrictions, and others), physical therapy, injections and medication. When severe, surgery has been an option for both joint and spine degenerative disease. Joint replacement, disc replacement and fusion were available to those with severe limitations in function related to the degenerative process.

These surgeries hold both great promise and great risk. Surgery results in irreversible structural change. It is a bridge burner in the respect that surgery forever changes the anatomy. In many cases surgical outcome is good and justifies this change in anatomy. In some, however, the change results in worsening of the original pain and overall worsening of function. Statistics show poorer outcomes with each successive surgery. Unfortunately, it is difficult, if not impossible to predict a successful surgical intervention in any individual patient.

Successful treatment is usually temporary and measured over years since surgical joint prosthetics wear out and require revision and replacement. Spine fusion speeds the degenerative process at adjacent vertebral levels.

Stem cell therapy, available now, is a means to stimulate healing in patients suffering both joint and disc related pain. Although we do not know how long lasting this treatment will be, we do know that the structure of the joint or spine is not changed with regenerative treatment.When patients are properly selected, outcomes are quite good. Best of all, stem cell treatment does not change anatomy and surgical options continue to be open and available if necessary.

View post:
Stem Cell Therapy - Stem Cells Heal Me

Get your Stem Cell Treatment in India with Dheeraj Bojwani Consultants

Stem Cell treatment is an intricate process. Stem Cell transplant patients need utmost care with respect to both emotionally and physically. Dheeraj Bojwani Consultants is a prominent medical tourism company in India making world-class medical facilities from best surgeons and hospitals accessible for international patients looking for budget-friendly treatment abroad.

Mrs. Marilyn Obiora - Nigeria Stem Cell Therapy For her Daughter in India

Hi, my name is Mrs. Marilyn Obiora, and I am from Nigeria. I came to India for my daughter's Stem Cell Therapy in India. My daughter had her first stroke in 2011. She couldn't sit, talk and had lost control of her neck. We could not find suitable help for her condition and searched for treatment in India.

We sent a query to the dheerajbojwani.com and received fast reply. Within no time we were in India for my daughter's treatment. We are very pleased with the treatment offered and there has been serious improvement in her condition in just two weeks. Thanks to the Dheeraj Bojwani Consultants, my daughter is regaining proper body functions and recuperating well.

Medical science has come a long way since its practice began thousands of years ago. Scientists are finding superior and more resourceful ways to cure diseases of different organs. Stem cells are undifferentiated parent cells that can transform into specialized cell types, divide further and produce more stem cells of the same group. Stem Cell therapy is performed to prevent or treat a health condition. Stem Cell Treatment is a reproductive therapy where nourishing tissues reinstate damaged tissues for relief from incurable diseases. Stem cell treatment is one of the approaches with a potential to heal a wide range of diseases in the near future. Science has always provided ground-breaking answers to obdurate health conditions, but the latest medical miracle that the medical fraternity has gifted to mankind is the Stem Cell Therapy.

Stem cell therapy is an array of techniques intended to replace cells damaged or destroyed by disease with healthy functioning ones. Even though the techniques are relatively new, their applications and advantages are broad and surprising the medical world with every new research. Stem cells are obtained from bone marrow or human umbilical cord. They are also known as the fundamental cells of our body and have the power to develop into any type of tissue cell in the body. Stem cell treatment is based on the principle that the cells move to the site of injury and transform themselves to form new tissue cells to replace the damaged ones. They have the capacity to proliferate and renew themselves indefinitely and can form mature muscle cells, nerve cells, and blood cells. In this type of therapy, they are derived from the body, kept under artificial conditions where they mature into the type of cells that are required to heal a certain part of the body or disease.

Stem cells are being studied and used to treat different types of cancers, disorders related to the blood, immune disorders, and metabolic disorders. Some other diseases and health conditions that may be healed using stem cell treatment are,

Recently, a team of researchers successfully secured the peripheral nerves in the upper arms of a patient suffering peripheral nerve damage, by using skin-derived stem cells (SDSCs) and a previously developed collagen tube, premeditated to successfully bridge gaps in injured nerves.

A research has found potential in bone marrow stem cell therapy to treat TB. Patients injected with new mesenchymal stromal cells derived from their own bone marrow showed positive response against the TB bacteria. The therapy also didnt show any serious adverse effects.

Stem cells are also used to treat hair loss. A small amount of fat is taken from the waist area of the patient by a mini-liposuction process. This fat contains dormant stem cells, and is then spun to separate the stem cells from the fat. An activation solution is added to the cells, and may be multiplied in number, depending on the size of the bald area. Once activated, the solution is washed off so that only cells remain. Now, the stem cells are injected into the scalp. One can find some hair growth in about two to four weeks.

Damaged cones in retinas can be regenerated and eyesight restored through stem cell. Stem cell therapy could regenerate damaged cones in people, especially in the cone-rich regions of the retina that provide daytime/color vision.

Kidney transplants have become more common and easier thanks stem cell therapy. Normally patients who undergo organ transplants need a lifetime of costly anti-rejection drugs but the new procedure may negate this need, with organ donors stem cells. Unless there is a perfect match donor, patients have to wait long for an organ transplant. Though still in early stages, the stem cell research is being considered as a potential player in the field of transplantation.

Transplanted stem cells serve as migratory signals for the brain's own neurogenic cells, guiding the new host cells towards the injured brain tissue. Stem cells have the potential to give rise to many different cell types that carry out different functions. While the stem cells in adult bone marrow tend to develop into the cells that make up the organ system from which they originated. These multipotent stem cells can be manipulated to take up the characteristics of neural cells.

Experts are using Stem cell Transplant to treat the symptoms of spinal cord injury by transplantation of cells directly into the gray matter of the patients spinal cord. Expectedly, the cells will integrate into the patients own neural tissue and create new circuitry to help transmit nerve signals to muscles. The transplanted cells may also promote reorganization of the spinal cord segmental circuitry, possibly leading to improved motor function.

Stem cells are capable of differentiating into a variety of different cell types, and if the architecture of damaged tendon is restored, it would improve the management of patients with these injuries significantly.

A promising benefit of stem cell therapy is its potential for cardiac tissue regeneration to reverse tissue loss underlying the development of heart failure after cardiac injury. Possible mechanisms of recovery include generation of heart muscle cells, stimulation of new blood vessels growth, secretion of growth factors.

It is a complex and multifarious procedure, with several risks and complications involved and is thus recommended to a few patients when other treatments have failed. Stem Cell therapy is recommended when other treatments fail to give positive results. The best candidates for Stem cell Treatment are those in good health and have stem cells available from a sibling, or any other family member.

India has been recognized as the new medical destination for Stem Cell therapies. Hundreds of international patients from around the world visit to India for high quality medical care at par with developed nations like the US, UK, at the most affordable costs. The Hospitals in India have the most extensive diagnostic and imaging facilities including Asias most advanced MRI and CT technology. India provides services of the most leading doctors and Stem Cell Therapy professionals at reasonable cost budget in the following cities

India offers outstanding Stem Cell Treatment at rates far below that prevailing in USA or other Western countries. Even with travel expenses taken into account, the comprehensive medical tourism packages still provide a savings measured in the thousands of dollars for major procedures. A cost comparison can give you the exact idea about the difference:

There are many reasons for India becoming a popular medical tourism spot is the low cost stem cell treatment in the area. When in contrast to the first world countries like, US and UK, medical care in India costs as much as 60-90% lesser, that makes it a great option for the citizens of those countries to opt for stem cell treatment in India because of availability of quality healthcare in India, affordable prices strategic connectivity, food, zero language barrier and many other reasons.

The maximum number of patients for Stem Cell Treatment comes from Nigeria, Kenya, Ethiopia, USA, UK, Australia, Saudi Arabia, UAE, Uzbekistan, Bangladesh

Below are the downloadable links that will help you to plan your medical trip to India in a more organized and better way. Attached word and pdf files gives information that will help you to know India more and make your trip to India easy and memorable one.

Back

Excerpt from:
Stem Cell Treatment in India - Dheeraj Bojwani

People considering stem cell treatment for arthritis want to know Is it safe? and Is it effective?

Most stem cell therapy using adult stem cells is considered safe because the stem cells are collected from the patient, minimizing the risk of an unwanted reaction. The most common side effects are temporary swelling and pain.3

While most stem cell therapy for arthritis is considered safe, it does carry the same risks as any other medical procedure, such as a small risk of infection. Risk may be increased if:

See What Are Stem Cells?

Some research suggests stem cell therapy engaging in these kinds of practices may elevate the risk of tumors.4

As with most regenerative medicine treatments, research is ongoing, and FDA regulations are relatively new and subject to change.

Article continues below

Whether or not stem cells therapy is effective in treating osteoarthritis is a controversial subject among medical professionals, and research in the area is ongoing.

See Osteoarthritis Treatment

How researchers think stem cell therapy worksResearchers theorize5 that when applied to an arthritic joint, stem cells might:

See Osteoarthritis Symptoms and Signs

It may be none, one, two, or all three processes at are work.

Proponents vs criticsLike many relatively new treatments, stem cell therapy has proponents and critics.

Critics emphasize that there have been no large-scale, prospective, double-blind research studiesthe kind of clinical studies that medical professionals consider the gold standardto support stem cell therapy for arthritis.

Factors that affect stem cell therapy researchAnother challenge associated with current stem cell research is that there is no standard stem cell therapy for arthritis treatment. So the stem cell therapy in one study is not necessarily the same as the stem cell therapy in another study.

Differences can include:

These differences are further complicated by more unknowns. For example, how many stem cells are needed for a particular treatment? And how do we determine if a patients own stem cells are competent enough to aid in healing?

Many physicians combine the use of stem cells with platelet rich plasma, or PRP.

See Platelet-Rich Plasma (PRP) Therapy for Arthritis

PRP is derived from a sample of the patients blood. In the body, platelets secrete substances called growth factors and other proteins that regulate cell division, stimulate tissue regeneration, and promote healing. Like stem cell therapy, PRP therapy is sometimes used alone with the hopes of healing an arthritic joint.

See PRP Injection Preparation and Composition

Physicians who use PRP and stem cells together think that the PRP can help maximize the healing effects of stem cells.7,8 Research in this area is ongoing.

See Platelet-Rich Plasma Injection Procedure

Stem cell therapy can vary depending on the doctor performing it. People considering stem cell therapy for an arthritic knee or other joint are advised to ask their doctors questions, including:

Both doctors and patients can benefit from having a frank conversation and setting reasonable expectations.

See Arthritis Treatment Specialists

Complete Listing of References

Visit link:
Is Stem Cell Therapy for Arthritis Safe and Effective?

Our Cell Therapy Center offers advanced patented methods of stem cell treatment for different diseases and conditions. The fetal stem cells we use have the highest potential for differentiation into other cell types and are not rejected by the recipients body read more...

Stem cell therapy has proven to be effective for tissue restoration, and integrated care for the incurable and obstinate diseases. We treat patients with diabetes mellitus, multiple sclerosis, Parkinsons disease, Duchenne muscular dystrophy, joint and autoimmune diseases, and other diseases and conditions. We also offer innovative anti-aging programs. Stem cell treatment allows for achieving effects that are far beyond the capacity of any other modern method read more...

For over 23 years, we have performed more than 9,400 transplantations of fetal stem cells to people from many countries, such as China, the USA, Saudi Arabia, UAE, Egypt, Great Britain, etc. Our stem cell treatments helped to prolong life and improve life quality to thousands of patients including those suffering from the incurable diseases who lost any hope for recovery.

Excerpt from:
Stem Cell Therapy & Stem Cell Treatment - Cell Therapy Center ...

If chronic joint pain is limiting your daily routine or preventing you from activities you enjoy; regenerative medicinemay be the answer youve been looking for!

The pharmaceutical approach to these conditions is still not effective for some 20% to 40% of those suffering from arthritis or other degenerative joint conditions. According to the National Institute of Health, Stem Cell Therapy provides a promising alternative to surgery by promoting safe and natural healing. The less invasive approach Stem Cell Therapy offers attracts thousands each year.Texas Spine and Sports Therapy Center is one of the few clinics in the country to offer Stem Cell Therapy. With convenient locations nearAustin, we are ready to get you back to the activity levels you desire.

Stem cells are found in all of us and play a key role in the bodys healing process. They lie latent in your body until they receive signals that the body has suffered an injury and then they follow your platelets to the injured site. Stem cells are able to transform into the same type of cell that was injured to promote healing. They are tasked to heal injured ligaments, tendons, tissues and bones. After an injury, or as a natural result of aging, the amount of stem cells needed in certain areas of the body declines. Stem Cell Therapy solves this problem by delivering a high concentration of stem cells into the injured area promoting natural healing.

The Stem Cell Therapy procedure is simple and takes just 15 minutes with pain relief in 24-48 hours. The therapy can be performed right in the Texas Spine and Sports Therapy Centeroffice and provides pain relief without the risks of surgery, general anesthesia, hospital stays or prolonged recovery. There is zero recovery time after Stem Cell Therapy. Most experience complete joint restoration of ligaments, tendons and cartilage in 28 days. Stem Cell Therapy is very safe and effective. The injections have been used over 10,000 times in the United States with no reported adverse side effects and have a 100% safety record in Europe with 100,000s of patients.

Stem cell treatment takes advantage of the bodys ability to repair itself. With Stem Cell Therapy, your Texas Spine and Sports Therapy CenterProvider will inject stem cells into your body. Similar to cortisone and steroid shots, stem-cell injections have anti-inflammatory properties, but offer far more benefits than those of standard injection therapies. While cortisone and other drugs only provide temporary pain relief, stem cells actually restore degenerated tissue while providing pain relief. The growth factors in Stem Cells may replace damaged cells in your body. Additionally, stem cell injections contain hyaluronic acid, which lubricates joints and tendons, easing the pain and helping restore mobility.

The Stem Cells can turn into any type of tissue found in joints other than nerve tissue. Depending on the different tissues that are damaged, the stem cells can turn into whatever your joint needs which can quite often be a combination of cartilage, ligament, tendon, bone or muscle. This is a curative treatment. You can literally grow new joints tissue. Once your joint is healed, it is healed. The oldest research to date shows that 100% of recipients who benefited from stem cell therapy were still pain free 4 years later. Stem Cell Therapy allows our state-of-the-art clinics across the Texas Hill Countryto treat and rehabilitate your pain and injuries without drugs or surgery.

Read the original post:
Stem Cell Therapy for Joints & Spine in Austin Texas

Harnessing stem cells to cure disease is the hottest topic in joint injury, knee pain and arthritis treatment today. By using the adult stem cells found in our own bodies, we can amplify and speed up the natural healing process as well as grow new bone and cartilage to rebuild joints without the need for artificial replacements.

At Cendant Stem Cell Centerin Denver and our new Milwaukee Wisconsin clinic, we provide our patients with the most recent technological advancements available for treating orthopedic injuries and conditions. Our Stem Cell therapy procedureprovides treatment to repair damaged cartilage, restore function, eliminate hip, shoulder, back and knee pain and to prevent further joint destruction.

The patients adipose (fat) derived Stem Cells and/or bone marrow derived Stem Cells are injected alongwith Platelet Rich Plasma into the joint capsule space. These components are put on top of an Extracellular Fiber Matrixwhich is injected into the joint capsule before the introduction of Stem Cells. This FDA approved fiberis a major advancement in the Stem Cell procedure which gives Stem Cells a structure to bind and growupon inside the joint space. The technology allows us to treat older patients and patients with more aggressive joint disease who are facing replacement surgery or suffering from chronic pain.

The Stem Cell procedureis virtually painless, takes 3 hours and is performed under local anesthesia. It requires little to no downtime and is effective, fast and safe. Please visit our Video Testimonials page to hear from our patients and why they choose our Denver and Milwaukee stem cell clinics for their medical needs.

Ourunique approach to stem cell therapy does not offer a single franchised solution. Cendants multiple technologies provide case-driven stem cell treatment options to address individual patient needs.

Medical researchers are reporting remarkable results using platelet rich plasma and stem cellsin the treatment of common injuries, including:

What should patients expect after Stem Cell Therapy?

The noticeable regeneration of the joint tissue and cartilage typically starts to occur within 3 weeks. Most of our patients report asubstantialreduction in pain and improved function within 4-6 weeksafter treatment. Many report total pain elimination within 10-12 weeks. Within 3-5 daysafter the procedure, most patients can return to work and resume normal daily activities. Patients cannot start stressful activity or begin strenuous exercise for six weeks. Returning to stressful activity before six weeks may result in incomplete healing of the treated tissue.

Is this therapy safe?

Yes. Autologous PRP therapy and Stem Cell therapy has been used for over 10 years in surgical and orthopedic procedures. There are many research articles published on the safety of these therapies. Because a patients own blood and cells are used, there is little risk of a transmissible infection, no side effects and a very low risk of allergic reaction.

How many treatments are required?

We treat most patients aggressively upon the first visit with a mix of PRP, Extracellular Fiber Matrix and Stem Cells which all work together to create yourregenerative injection. Most patients need only 1 treatment but you could potentially have a follow up pure PRP injection which is thought of as a booster shot, the primary function of which is to stimulate continual stem cell growth.

Link:
Stem Cell Therapy - Cendant Cellular Therapies - Denver ...

At Scott Medical Center, non-invasive medical procedures are the mainstay of our practice. Using the most up to date techniques, our staff treats patients as whole people, providing a comprehensive diagnostic assessment in order to design a customized strategy for relief from medical concerns. Stemcell research, for example, has advanced to a point that, at Scott Medical Center, stemcell injections as part of our array of treatments, designed to help our patients attain their wellness goals and achieve a higher quality of life.

For instance, until recently, treatment options for people with osteoarthritis of the knee were limited. Steroid injections, joint replacement surgery, and physical therapy were often the only treatment options. Now, stemcell injections for knee osteoarthritis are available, at Scott Medical Center. Stemcell therapy also has applications for treating Achilles tendonitis, rotator cuff tendonitis, and degenerative arthritis.

Stemcell injections work with the bodys natural ability to heal itself. Unlike treatments that simply address the symptoms, stemcell therapy actually promotes repair of the body, restoring degenerated tissue. Stemcell injections also contain hyaluronan, which eases pain and restores mobility by lubricating joints and tendons. This therapy fits well with Scott Medical Centers integrated approach to wellness, addressing the source of issues, rather than just treating the symptoms.

Excerpt from:
Stem Cell Therapy - Scott Medical Center

Chiesi's Holoclar, the first stem-cell therapy to be cleared by European regulators, has received a green light for use on the NHS in England and Wales to treat a rare sight condition.

The National Institute for Health and Care Excellence has now published final guidelines backing Holoclar as an option to treat adults with moderate to severe limbal stem cell deficiency (LSCD) after eye burns.

However, the guidelines state the therapy can only be used to treat one eye and in those who have already had a conjunctival limbal autograft, or there is not enough tissue for a conjunctival limbal autograft or it is contraindicated.

Holoclar is now also recommended in adults with moderate to severe LSCD after eye burns for treating both eyes only in the context of research, and when there is not enough tissue for a conjunctival limbal autograft.

LSCD is a seriously debilitating condition affecting one or both eyes, most commonly from chemical or physical ocular burns. If left untreated, it can cause chronic pain, burning, photophobia, inflammation, corneal neovascularisation, stromal scarring and the reduction or complete loss of vision.

Holoclar uses a patients own stem cells to regenerate and repair damaged eye tissue and is the first advanced therapy medicinal product containing stem cells as the active substance to win approval in Europe, back in 2015. It also won the UK Prix Galien Orphan Product award for innovation and research in 2016.

Chiesi says it is extremely pleased with NICEs decision, which will reduce the need for external donors and damage to the donor eye.

We are delighted that NICE has recommended that eligible patients have access to this personalised and regenerative medicine for a rare and seriously debilitating orphan condition, said Chiesi's UK managing director Tom Delahoyde.

Read more:
Europe's first stem cell therapy backed by NICE - PharmaTimes - PharmaTimes

An English bulldog undergoes surgery for spina bifida at the UC Davis Veterinary Medical Teaching Hospital. The dog is part of a pair of puppies being treated for spina bifida through a combination of stem cell therapy and surgery, research made possible through collaboration between the UC Davis School of Veterinary Medicine and UC Davis Health. Credit: Gregory Urquiaga/UC Davis

A pair of English bulldog puppies are the first patients to be successfully treated with a unique therapya combination of surgery and stem cellsdeveloped at the University of California, Davis, to help preserve lower-limb function in children with spina bifida.

Because dogs with the birth defect frequently have little control of their hindquarters, they also have little hope for a future. They are typically euthanized as puppies.

At their postsurgery re-check at 4 months old, however, the siblings, named Darla and Spanky, showed off their abilities to walk, run and play to their doctor, veterinary neurosurgeon Beverly Sturges.

"The initial results of the surgery are promising, as far as hind limb control," said Sturges. "Both dogs seemed to have improved range of motion and control of their limbs."

The dogs have since been adopted, and continue to do well at their home in New Mexico.

A major step toward curing spina bifida

Spina bifida occurs when spinal tissue improperly fuses in utero, causing a range of cognitive, mobility, urinary and bowel disabilities in about 1,500 to 2,000 children born in the U.S. each year. The dogs' procedure, which involved surgical techniques developed by fetal surgeon Diana Farmer of UC Davis Health together with a cellular treatment developed by stem cell scientists Aijun Wang and Dori Borjesson, director of the university's Veterinary Institute for Regenerative Cures, represents a major step toward curing spina bifida for both humans and dogs.

Farmer pioneered the use of surgery prior to birth to improve brain development in children with spina bifida. She later showed that prenatal surgery combined with human placenta-derived mesenchymal stromal cells (PMSCs), held in place with a cellular scaffold, helped research lambs born with the disorder walk without noticeable disability.

Sturges wanted to find out if the surgery-plus-stem-cell approach could give dogs closer-to-normal lives along with better chances of survival and adoption. At 10-weeks old, Darla and Spanky were transported from Southern California Bulldog Rescue to the UC Davis veterinary hospital, where they were the first dogs to receive the treatment, this time using canine instead of human PMSCs.

Another distinction for Darla and Spanky is that their treatment occurred after birth, since prenatal diagnosis of spina bifida is not performed on dogs, Sturges explained. The disorder becomes apparent between 1 and 2 weeks of age, when puppies show hind-end weakness, poor muscle tone, incoordination and abnormal use of their tails.

A unique environment for collaborative research

UC Davis is the only place where this type of cross-disciplinary, transformational medicine could happen, according to Farmer.

"It's rare to have a combination of excellent medical and veterinary schools and strong commitment to advancing stem cell science at one institution," she said.

UC Davis is also home to the One Health initiative aimed at finding novel treatments like these for diseases that affect both humans and animals.

"I've often said that I have the greatest job on the planet, because I get to help kids," Farmer said. "Now my job is even better, because I get to help puppies too."

Hopes for clinical trials in humans and dogs

With additional evaluation and U.S. Food and Drug Administration approval, Farmer and Wang hope to test the therapy in human clinical trials. Sturges and Borjesson hope to do the same with a canine clinical trial. They hope the outcomes of their work help eradicate spina bifida in dogs and humans.

In the meantime, the team wants dog breeders to send more puppies with spina bifida to UC Davis for treatment and refinements that help the researchers fix an additional hallmark of spina bifidaincontinence. While Darla and Spanky are very mobile and doing well on their feet, they still require diapers.

"Further analysis of their progress will determine if the surgery improves their incontinence conditions," Sturges said.

Explore further: Prenatal stem cell treatment improves mobility issues caused by spina bifida

See original here:
Stem cell treatment for children with spina bifida helps dogs first - Phys.Org

Hope is surely on the way for children with special needs as Alok Sharma, a world renowned neurosurgeon, Neuroscientist and professor, a director of NeuroGen Brain and Spine Institute India visited Nigeria recently to shed light on the efficacy of stem cells in treating children with special needs.With over 5000 patients treated from 50 countries, 68 scientific papers and 14 published books, and an overall 91% success rate, Alok was determined to enlighten participants who attended the one day seminar on stem cell awareness and its importance.According to Asok, We are the pioneers of introduction to Stem Cell Therapy for neurological disorders. We make use of holistic, comprehensive approach to treat our patients with a combination of stem cell therapy and neuro-rehabilitation. We use adult stem cells derived from the patients own bone marrow, as they are the safest and most feasible type of cells. Since every patient is different, our treatment protocol is customised according to the patients requirements.We now have a treatment that is very effective and a large number of people can benefit from this. The old thinking was that when the central nervous system is damaged then it is beyond repairs but the new thinking is that some degree of repair is possible. Stem cells have three capabilities. They repair, regenerate or replaced. It took us between seven to eight years to prove that stem cells can convert to nerve cells and when we became very sure, we went on to use on humans and the results have been outstanding He said.Asked who can be treated with the stem cell procedure and Asok says for paediatric, we treat children with autism, cerebral palsy, intellectual disability and muscular dystrophy. For adults, we treat spinal cord injury, stroke, traumatic brain injury/head injury, motor neuro disease/amyotrophic lateral scierosis and other neurological disorders.Asok explains that there are many types of stem cells used, but broadly they can be classified into 3 types:-Embryonic stem cells: Embryonic stem cells, as their name suggests, are derived from 3-4 day embryos. These are obtained from spare embryos from IVF clinics with the consent of the donor. During this early developmental period, the cells that will ultimately give rise to the developing fetus can be encouraged to develop into tissues of different origins (totipotency) contributing greatly to stem cell therapy. However, there are many ethical and medical issues regarding its use. These are therefore, not being used presently.Umbilical cord stem cells: These cells are derived from the umbilical cord which connects the baby and the mother at birth. Stem cells derived from the umbilical cord are stored by various cord blood banking companies. These stem cells do not have any major ethical issues surrounding their usage, but availability can be a problem.Adult stem cells: They can be derived from the same patient, from either the hip bone or the adipose/fat tissue. Currently, they are the most popularly used stem cells. The benefits that adult stem cells offer are:1, They are available in abundance and can be isolated easily.2, They are isolated from patients, which overcomes the problem of immunological rejection.3, Adult stem cells have the potential to replenish many specialized cells from just a few unspecialized ones.4, They do not have any ethical issues as they do not involve destruction of embryos.5, The risk of tumor formation is greatly reduced as compared to the use of embryonic stem cells.There are fears about stem cell therapy but Asok cleared the air when he said this isnt the truth as the one feared is the embryonic stem cells (ESCs) which are stem cells derived from the undifferentiated inner mass cells of a human embryo. ESCs are just one of the types of stem cells but we do not make use of that in our hospital as explained earlier, we use Adult Stem Cells. We do not use the embryotic stem cells because they have the tendency to become tumours in the body. He explained.On how the procedure works, he says a thin needle is inserted into the hip bone to pull the marrow out. The procedure takes between 15 to 30 minutes. The patient is then sent back to the room for about 3 to 4 hours to rest for the next procedureon same day, within the 2 to 4 hours, the stem cells are separated and purified in their stem cell laboratory by using density gradient centrifugation. Once the stem cells have been purified, the patient is taken back to the operation theatre and the stem cells are injected into the spinal space. In some patients, for instance, patients with muscular dystrophy, the stem cells are diluted and injected into the muscles using a very thin needle.One of the participants at the seminar, Marvis Isokpehi, whose child is autistic, had this to say I am glad I came for this seminar. Initially, we were told anything that has to do with brain damage cannot be cured or improved only managed but we see that God helping the scientist, things are getting better. My child was diagnosed by 2. She walked at 17 months, sat at 8 months and she only babbled. She could use her hands and able to put things in her mouth herself but later, the growth began to drop and along the line, I took up the challenge and went back to school to learn about taking care of her and also to help others. I went to Federal College of Education (special) Oyo and specialised in Education for the intellectually disabled. Said Marvis.For Akhere Akran, the Manager of Agatha Obiageli Aghedo Memorial Foundation and participant, one of the arms of our foundation aimed at helping to lessen the burden of the less privileged in the community is the St Agatha Children Centre, where we advocate for children with special needs. I am glad I will be going back to let the parents of these children know there is hope and I am trusting God for funds because that is truly the core of everything. I appeal to the government to fund this and encourage private organisations to help reduce the cost of this treatment to the barest minimum. Its high time we stop stigmatisation or thinking its a result of the mothers past life of the fathers mistakes. It is a medical situation that needs medical attention. Akran expressed.Andelene Thysse is a director at Stem Cell Africa and she helped facilitate the seminar and for her, it is high time Nigeria gets involved We are currently looking at establishing a stem centre at Mozambique. I would have loved that we establish in Nigeria because Nigeria is closer to everything but since we arent getting the audience required, we are going to other African countries interested. Going to NeuroGen Institute for treatment per patient costs about $11,000 imagine if Nigeria has the facility, the price can slash down to $6,000 or even below Andelene stated.Shedding more light on costing, Asok says If we are to set up such a facility in an existing hospital, the cost of setting it up is $US500, 000 and I am assuming all facilities are functioning already. If we have to set up as a whole which includes getting land and building, it will be more expensive. This may sound expensive but it is worth it because it will save you the stress for the future. More important than the money is the permission from the government of the country. The government has to give us the permission because it is what is happening in other African countries. We have had good response and cooperation from government in Kenya, South Africa and Zimbabwe. We have quite a number of Nigerians who come to us in India for this treatment. We treat 50 patients from around the world per week about 5-10 are from Africa and Nigeria is among this percentage.

Kemi Ajumobi

Read more:
Stem cell therapy: proffering hope for special needs patients ... - BusinessDay (satire) (press release) (registration) (blog)

Recently Dr Pradeep V Mahajan was honoured with Paris Appreciation Awards, 2017 for Excellence in stem cell therapy. He is the Chairman and Managing Director of StemRx Bioscience Solutions Pvt Ltd. In an interview with ETHealthworld, Dr Mahajan talks about the latest advancements in stem cell therapy and where it stands in healthcare system today. Edited excerpts :

How well informed are the doctors today about the cellular therapy? Is it time consuming? Where does cellular therapy stand in the Indian Healthcare system today?

For more than four decades, medical fraternity has knowledge about stem cell science and its potential therapeutic applications. However, earlier, clinicians were commonly aware of hematopoietic stem cell therapy, but were relatively uninformed about the advantages of mesenchymal stem cells. This could be attributed to the medical course syllabus which initially did not include topics specifically on cellular therapy.

Despite the technological advances that medical science is witnessing, it is not possible at present to predict the exact time when cellular therapy and regenerative medicine will replace existing forms of pharmacological and surgical treatments. Nonetheless, there is increasing awareness amongst clinicians who now more receptive to and are advising cell based therapy as an effective therapeutic modality for treatment of diseases.

Which are the diseases that can be treated through cellular therapy? What are the latest advancements?

Cellular therapy and regenerative medicine focuses on eliminating the root cause of the problem by use of cells (cytokines, chemokines etc.), growth factors from ones own body. Orthopedic conditions such as avascular necrosis, osteoarthritis, autoimmune conditions such as rheumatoid arthritis, ankylosing spondylitis, neurological conditions such as cerebral palsy, stroke etc., as well as diabetes, liver, genitourinary disorders, dermatological conditions and many more can achieve benefits from cellular therapy. This form of therapy can be further explored in management of organ failure, to overcome rejection following organ transplants, developmental defects, cancer immunotherapy etc.

Research advances pertaining to introducing products with cell and scaffold based technology through tissue engineering are underway. Bioactive scaffolds that are capable of supporting activation and differentiation of host stem cells at the required site are being developed. In the future it will be possible to use human native sites as micro-niche/micro-environment for potentiation of the human body's site-specific response.

Technologically, advances have been made over the years in both diagnostic and therapeutic approaches. Molecular imaging technology (optical imaging, positron emission tomography etc.) has simplified research on disease mechanism and treatment evaluation related to cell based therapy. Several new technologies are being introduced that simplify the process of isolation and characterization of cells. One such example is the Prodigy technology which completely automates the procedure of cell manufacturing from start to finish, thus enabling standardization and GMP compliance. In addition, detection and identification of specific cell populations is now possible through gene labeling techniques. Similarly, advances in microscopy have enabled study of cell behavior with respect to their surroundings.

What is the scope of cellular therapy in the country?

India is a nation with increasing population demands. Our country is seeing an alarmingly rapid rise in occurrence of diseases and conventional treatment modalities are gradually losing potential to cure affected individuals. Being a developing economy, the application and opportunity of cellular therapy and regenerative medicine is different when compared to other countries. A number game exists between diseases (such as cancer, lifestyle related, autoimmune conditions etc.) and finances in our country. The aim of cellular therapy is to enable a diseased person to use his own body cells for treatment thereby addressing the issue of extreme financial burden as seen with conventional treatment modalities. This will drastically benefit our patients and country and will also propagate India towards becoming the leader in cellular therapy and regenerative medicine.

Go here to read the rest:
Cell based therapy is gaining momentum : Dr Pradeep V Mahajan - ETHealthworld.com

University of North Carolina Health Careresearchers have made strides toward a stem cell treatment for lung diseases such as pulmonary fibrosis, COPD, and cystic fibrosis.

In fact, they are discussing the start of clinical trials with regulatory authorities.

The team discussed its work in two recent studies. One provedthat it is possible to isolate lung stem cells with a relatively non-invasive procedure. The other showed that stem cells reduce fibrosis in rats with pulmonary fibrosis.

The first study, in the journal Respiratory Research, was titledDerivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies.The second, inStem Cells Translational Medicine, was Safety and Efficacy of Allogeneic Lung Spheroid Cells in a Mismatched Rat Model of Pulmonary Fibrosis.

This is the first time anyone has generated potentially therapeutic lung stem cells from minimally invasive biopsy specimens, Dr. Jason Lobo, director of the universitys lung transplant and interstitial lung disease program,said in a press release. Hewas co-senior author of both studies.

We think the properties of these cells make them potentially therapeutic for a wide range of lung fibrosis diseases, added Dr. Ke Cheng, who led the studies with Lobo. He is anassociate professor in North Carolina State Universitys Department of Molecular Biomedical Sciences.

The research team had previously homed in on stem and support cells they could isolate from a lung tissue sample and grow in a lab. The tissue formed sphere-like structures in a lab dish, prompting the scientists to call them lung spheroid cells.

In 2015, the team showed that these cells had potent regenerative properties in animals with lung diseases. In fact, the stem cells they cultivated outperformed another type called mesenchymal stem cells.

Their latest project involved gathering lung spheroid cells from patients with various lung diseases. They used a procedure calleda transbronchial biopsy thatcan be done in a doctors office.

We snip tiny, seed-sized samples of airway tissue using a bronchoscope, Lobo said. This method involves far less risk to the patient than does a standard, chest-penetrating surgical biopsy of lung tissue.

From this tiny piece of airway, researchers gathered stem cells, then allowed them to multiply because stem cell treatments require infusions of millions of such cells.

When they injected the cells intravenously into mice, the discovered that most found their way into the animals lungs.

These cells are from the lung, and so in a sense theyre happiest, so to speak, living and working in the lung, Cheng said.

The team then tested the treatment in rats exposed to a chemical that triggers lung fibrosis. The lung spheroid cells gave rise to healthy lung cells, reducing both inflammation and fibrosis in the animals lungs.

Also, the treatment was safe and effective whether the lung spheroid cells were derived from the recipients own lungs or from the lungs of an unrelated strain of rats, Lobo said. In other words, even if the donated stem cells were foreign, they did not provoke a harmful immune reaction in the recipient animals, as transplanted tissue normally does.

The researchers said that in humans their goal would be to use patients own stem cells to minimize the risk of immune reactions. But because large quantities of cells are needed, it might be necessary to gather cells from healthy volunteers or organ donation networks as well.

Our vision is that we will eventually set up a universal cell donor bank, Cheng said.

The team is in discussions with the U.S. Food and Drug Administration aimed at starting the first human study by years end. The first trial would include a small group of pulmonary fibrosis patients. The team also hopes their spheroid stem cell therapy will help patients with other lung diseases.

Read the original:
Trial of Lung Disease Stem Cell Therapy Could Come by Year's End - Lung Disease News

Chiesi made history two years ago when it claimed the first approval in Europe for a stem cell therapy, and can now celebrate decision by NICE to recommend its product for routine use in England and Wales.

The therapy - called Holoclar - was approved in 2015 for adults with moderate to severe limbal stem cell deficiency (LSCD) caused by physical or chemical burns to the eyes. LSCD is a rare condition that can lead to blindness, and affects just 3.3 out of 100,000 people in the EU.

Corneal cell renewal and repair are dependent upon the cells present in the limbus, which is found in a small area of the eye between the cornea and the conjunctiva. Burns to the eye can destroy the limbus, causing a deficiency of limbal cells. If this happens, the cornea is covered by a different epithelium following an invasion of cells from the conjunctiva. This process renders the cornea opaque and results in subsequent loss of vision, and conventional corneal transplant is ineffective in these cases.

Holoclar takes the form of a sheet of corneal epithelial cells, containing the patient's own stem cells, that can be used to regenerate and repair damaged eye tissue.

The therapy has been approved with some conditions by NICE. Specifically, it can generally only be used to treat one eye, and to be eligible patients must have previously had treatment with a conjunctival limbal autograft (CLAU) - a form of transplant surgery that involves taking tissue from an unaffected eye - or be unsuitable for that procedure.

Patients with two eyes affected by LSCD can only receive the therapy in the context of research if there is not enough tissue available for a CLAU, according to NICE, which said its appraisal committee had agreed that Chiesi had presented evidence to show that Holoclar "offered several advantages over existing treatments".

Chiesi has agreed to supply Holoclar to the NHS at an undisclosed discount to its list price of 80,000 plus VAT for a single treatment for one eye. The company said the decision will reduce the need for external donors and damage to the donor eye.

"We are delighted that NICE has recommended that eligible patients have access to this personalised and regenerative medicine for a rare and seriously debilitating orphan condition," commented Chiesi's UK managing director Tom Delahoyde.

Holoclar - which won the UK Prix Galien award in 2016 - is the first product from Chiesi's nine-year-old rare disease unit to reach the market, although it could shortly be joined by Lamazym/Lamzede (velmanase alfa), used as an enzyme replacement therapy for the genetic disorder alpha-mannosidosis which is currently under review in Europe.

Visit link:
NICE backs Europe's first stem cell therapy - PMLiVE

According to data released by the Food and Waterborne Diseases Office of the Health Ministry, an average of 15% of hospital patients suffer from nosocomial infections.A nosocomial infection is an infection acquired in hospital by a patient who was admitted for a reason other than the infection.The severity of hospital-acquired infections depends on the location and type of infection, said Abbasali Imani Fouladi, the scientific secretary of the 18th International Congress of Microbiology, which will be held on Aug. 29-31 at Tehran University of Medical Sciences, ISNA reported. The use of stem cells and their significant role in treatment of the infectionsin particular, antibiotic-resistant infectionsis a key topic that will be discussed by domestic and foreign specialists at the conference.Sometimes ulcers which are resistant to conventional treatment, respond positively and swiftly to stem cell treatments, he explained, adding that officials from Council for Stem Cell Sciences and Technologies (affiliated to Vice-Presidency for Science and Technology) have been invited to the event that will be attended by scientists from Spain, Italy, UK, and France. Four workshops will be held on the sidelines of the meeting.Stating that with resistance to antibiotics becoming more common, there is greater need for alternative treatments, he said, Currently there are 12 strains of bacteria in need of new antibiotics or alternative treatments.The event is co-sponsored by the Health Ministry, TUMS, Pasteur Institute of Iran, Razi Vaccine and Serum Research Institute, and Ilam University of Medical Sciences, according to the congress website (ismcongress.ir).Nosocomial infections occur worldwide and affect both developed and resource-poor countries. Healthcare-associated infections are among the major causes of death and increased morbidity among hospitalized patients. They are a significant burden both for the patient and public health.According to the World Health Organization, HAIs add to functional disability and emotional stress of the patient and may in some cases, lead to disabling conditions that reduce the quality of life. Nosocomial infections are also one of the leading causes of death. The economic costs are considerable. The increased length of hospital stay for infected patients is the greatest contributor to cost.While the prevalence rate of HAIs is 30% in lower-income countries, the average rate is around 6-11% in developed countries, according to Dr. Hossein Masumi-Asl, head of the Food and Waterborne Diseases Office.The most frequent nosocomial infections are infections of surgical wounds, urinary tract infections and lower respiratory tract infections, he said. According to the official, the highest prevalence of nosocomial infections occurs in intensive care units and in acute surgical and orthopedic wards. Infection rates are higher among patients with increased susceptibility because of old age, underlying disease, or chemotherapy.

The rest is here:
Stem Cell Therapy for Infections by Resilient Bacteria - Financial Tribune

By: PTI | Los Angeles | Published:August 15, 2017 6:54 pm Understanding the critical role metabolism plays in hair growth and stem cells.

Scientists have discovered a new way to activate the stem cells in the hair follicle, an advance that may pave the way for novel drugs to promote hair growth. Hair follicle stem cells are long-lived cells in the hair follicle; they are present in the skin and produce hair throughout a persons lifetime. They are quiescent, meaning they are normally inactive, but they quickly activate during a new hair cycle, which is when new hair growth occurs.

The quiescence of hair follicle stem cells is regulated by many factors. In certain cases they fail to activate, which is what causes hair loss.

Researchers from University of California, Los Angeles in the US found that hair follicle stem cell metabolism is different from other cells of the skin. Cellular metabolism involves the breakdown of the nutrients needed for cells to divide, make energy and respond to their environment. The process of metabolism uses enzymes that alter these nutrients to produce metabolites.

As hair follicle stem cells consume the nutrient glucose a form of sugar from the bloodstream, they process the glucose to eventually produce a metabolite called pyruvate. The cells then can either send pyruvate to their mitochondria the part of the cell that creates energy or can convert pyruvate into another metabolite called lactate. Our observations about hair follicle stem cell metabolism prompted us to examine whether genetically diminishing the entry of pyruvate into the mitochondria would force hair follicle stem cells to make more lactate, and if that would activate the cells and grow hair more quickly, said Heather Christofk, an associate professor at UCLA.

The research team first blocked the production of lactate genetically in mice and showed that this prevented hair follicle stem cell activation. Conversely, they increased lactate production genetically in the mice and this accelerated hair follicle stem cell activation, increasing the hair cycle. Before this, no one knew that increasing or decreasing the lactate would have an effect on hair follicle stem cells, said William Lowry, a professor at the UCLA.

Once we saw how altering lactate production in the mice influenced hair growth, it led us to look for potential drugs that could be applied to the skin and have the same effect, said Lowry. The team identified two drugs that, when applied to the skin of mice, influenced hair follicle stem cells in distinct ways to promote lactate production.

The first drug, called RCGD423, activates a cellular signalling pathway called JAK-Stat, which transmits information from outside the cell to the nucleus of the cell. The research showed that JAK-Stat activation leads to the increased production of lactate and this in turn drives hair follicle stem cell activation and quicker hair growth. The other drug, called UK5099, blocks pyruvate from entering the mitochondria, which forces the production of lactate in the hair follicle stem cells and accelerates hair growth in mice.

Through this study, we gained a lot of interesting insight into new ways to activate stem cells, said Aimee Flores, first author of the study published in the journal Nature Cell Biology. The idea of using drugs to stimulate hair growth through hair follicle stem cells is very promising given how many millions of people, both men and women, deal with hair loss, said Flores.

I think weve only just begun to understand the critical role metabolism plays in hair growth and stem cells in general; Im looking forward to the potential application of these new findings for hair loss and beyond, she said.

For all the latest Lifestyle News, download Indian Express App

More:
Potential stem cell therapy may help promote hair growth - The Indian Express

Q: I read that you can use your own stem cells to rejuvenate worn-out knees. Does this really work?

A: Worn out is a good way to term what happens to the knee joint with prolonged use. Lets look at how this happens, starting with cartilage.

The lower portion of the knee joint (at the tibia) contains shock absorbers called menisci made of cartilage. You have one on the inner portion and another on the outer portion of each knee. The upper portion of the knee joint (at the femur) is lined with cartilage as well. All of this cartilage helps protect the bones at the joint but it doesnt heal or regenerate well due to limited blood supply. When severe, worn cartilage leads to arthritis of the knee. In knee X-rays of people over age 60, 37 percent have shown evidence of arthritis of the knees.

The intriguing thing about stem cells is that they have the ability to become any type of cell that the body needs. The cells used for stem cell injections in the knees are called mesenchymal stem cells, and they can differentiate into bone, fat or cartilage cells. These stem cells can come from the fat cells of your body, from your bone marrow or from the inner lining of your knee joint; theyre then replicated in the laboratory and injected into the knee joint.

Heres what the research shows so far.

In a 2013 study, 32 patients with meniscal tears of the knee were injected with a combination of stem cells, platelet-rich plasma and hyaluronic acid. The study reported improved symptoms and even MRI evidence of meniscal cartilage regeneration.

In a 2014 study, 55 patients who had surgery for meniscal tears of the knees were separated into three groups, with two of the groups receiving stem cell injections. Researchers found that, after six weeks, pain had decreased substantially in the two groups that received stem cell injections and that the decrease was even greater at one and two years after the injection.

In a 2017 study in the British Journal of Sports Medicine, researchers analyzed six studies that used stem cells for osteoarthritis of the knees. In five of the studies, stem cells were given after surgery to the knee; in the other study, stem cells from a donor were administered without surgery. All the studies showed reduced pain and improved knee function. Further, in three of the four trials, MRIs corroborated the cartilage improvements.

There may be benefit to stem cell injections for cartilage loss of the knees, but more data are needed. Id also like to see more data on this type of therapy as a preventive measure for younger patients before their knees are worn out.

ASK THE DOCTORS is written by Robert Ashley, M.D., Eve Glazier, M.D., and Elizabeth Ko, M.D. Send questions to askthedoctors@

mednet.ucla.edu, or write: Ask the Doctors, c/o Media Relations, UCLA Health, 924 Westwood Blvd., Suite 350, Los Angeles, CA, 90095.

Read the original here:
Stem cell therapy may help knees - News - Citizens' Voice - Citizens Voice

In the days after a heart attack, surviving patients and their loved ones can breathe a sigh of relief that the immediate danger is over but the scar tissue that forms during the long healing process can inflict lasting damage. Too often it restricts the hearts ability to fill properly between beats, disrupting rhythm and ultimately leading to heart failure. Yet a new possible treatment may help to revitalize an injured ticker.

A cadre of scientists and companies is now trying to prevent or reverse cardiac damage by infusing a cocktail of stem cells into weakened hearts. One company, Melbourne, Australiabased Mesoblast, is already in late-stage clinical trials, treating hundreds of chronic heart failure patients with stem cell precursors drawn from healthy donors hip bones. A randomized trial that includes a placebo group is scheduled to complete enrollment next year.

Mesoblasts earlier-stage trials, published in 2015 inCirculation Research, found that patients who received injections of its cell mixture had no further problems related to heart failure.

Promising results from the new trial would be a major step forward for a field that has long been criticized for studies that are poorly designed, incomplete or lack control-group comparisons, as well as for the peddling of unproved therapies in many clinics worldwide.

Another company, Belgium-based TiGenix, hopes to attack scar tissue before it forms by treating patients with a mixture of heart stem cells within seven days of a heart attack. This approach has just completed phase II trials, but no findings have yet been published.

There are still many unanswered questions about how stem cells typically derived from bones could help heal the heart. Leading theories suggest they may help fight inflammation, revitalize existing heart cells, or drive those cells to divide or promote new blood-vessel growth, says Richard Lee, leader of the cardiovascular program at the Harvard Stem Cell Institute. Other stem cell scientists, including Joshua Hare, who conducted earlier-stage Mesoblast research and directs the Interdisciplinary Stem Cell Institute at the University of Miami, say the cells may work in multiple ways to heal scar tissue. According to Hare, the stem cells could ultimately be a truly regenerative treatment.

Read the original post:
Stem cell therapy for heart failure gets a gold-standard trial - Salon

The two entities join hands for all-inclusive stem cell treatment in Los Algodones, Tijuana, and Guadalajara. Package includes personalized therapy protocol, travel assistance, and more. GIOSTAR is a global stem cell leader with more than 4,000 people treated.

DALLAS-August 14, 2017- (Newswire.com)

The major medical tourism facilitator has added another much-needed treatment to its comprehensive list of medical services, stem cell treatment in Mexico, as a way of helping people with degenerative, immunological, and blood-based diseases receive alternative healthcare and lead a happy, healthy life.

About GIOSTAR Mexico

Founded by a leading stem cell scientist, Dr. Anand Srivastava who is credited with setting up stem cell research programs in Sal Research Institute, UCSD, UCI and Sanford Burnham Institute, GIOSTAR is a visionary organization in the field. With its headquarters in San Diego and multiple top-notch facilities, offices and hospitals in various locations including India, Mexico, Brazil and Colombia, the venture is expanding its reach and making treatment for several devastating immunological and blood- related diseases accessible for all.

GIOSTAR Mexico offers stem cell therapy in Tijuana, Guadalajara, and Los Algodones. Current treatments include Diabetes Type I and Type II, Lupus, Multiple Sclerosis, Crohn's disease, and Spinal Cord Injuries (SCI), among others. The therapies for Alzheimer's, Autism, Anti-Aging Treatments, Parkinson's disease, Heart and Retinal Degeneration, and many more diseases are being developed by the dedicated and skilled members of the institute.

Some prominent features of GIOSTAR are:

About Medical Tourism Corporation (MTC)

The Texas-based Medical Tourism Corporation is a Better Business Bureau (BBB) accredited health tourism organizer. The corporation aims to connect medical tourists from all over the world to excellent healthcare services without the underlying stress. The most daunting part of the medical tourism process is the lack of information about quality treatments in Mexico, India, and other health tourism hubs. MTC emerges as a helping hand, and assists its customers in planning every little detail of their medical trip and even offers generous post-op services and follow-up care for a safe recovery.

With the introduction of alternative therapies for taxing and draining conditions, such as stem cells for Parkinson's in Mexico, the organization is expanding its arsenal of services and treatments offered.

Medical Tourism Corporation has recently partnered with GIOSTAR with the goal of making quality healthcare come true. The two entities have collaborated to offer personalized protocols for various conditions and injuries, including stem cell therapy for spinal injuries in Mexico.

Aiming to provide exemplary stem cell treatment in Mexico, MTC provides a host of services and features that set the venture apart:

What to Expect?

The National Institutes of Health (NIH) estimates up to 23.5 million Americans suffer from autoimmune diseases. All that is standing between these patients and life-altering medical treatments is a border away.

This timely collaboration between GIOSTAR and MTC is an important step forward in bridging the gap between demand and supply of effective alternative treatments for people suffering from the aforementioned ailments when conventional therapies fail to treat. More information on stem cell therapy in Mexico is available on the official website of Medical Tourism Corporation.

Related LinksStem Cell Treatment for Diabetes Type 1 and 2 in MexicoStem Cell Treatment for Arthritis in Mexico

Related Images

Press Release Serviceby Newswire.com

Original Source: Medical Tourism Corporation Announces Stem Cell Therapy in Mexico With GIOSTAR

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and have questions or removal reuqests please contact pressreleases@franklyinc.com

Read the original:
Medical Tourism Corporation Announces Stem Cell Therapy in Mexico With GIOSTAR - NBC Right Now

Researchers have created a method to kill cancerous tissue without causing the harmful side effects of chemotherapy.

Medical researchers at the University of California, Irvine have created a stem cell-based method to zero in on cancerous tissue. This method kills the cancerous tissue without causing the nasty side effects of chemotherapy. Such side effects are avoided by treating the disease in a more localized manner. The advancement was spearheaded by associate professor of pharmaceutical sciences Weian Zhao. The details of the stem cell therapy were recently published in Science Translational Medicine.

About the new Stem Cell Therapy

Zhao's team programmed stem cells derived from human bone marrow to pinpoint the specific properties of cancerous tissue. They implemented a portion of code to these engineered cells to identify stiff cancerous tissue, lock onto it and implement therapeutics. The researchers safely used this new stem cell therapy in mice to kill metastatic breast cancer that had moved to the lungs. They transplanted these engineered stem cells in order for the teamto pinpoint and settle in the site of the tumor.

Once the stem cells reached the tumor, they released enzymes referred to as cytosine deaminase. The mice were then provided with an inactive chemotherapy known as prodrug 5-flurocytosine. The tumor enzymes stimulated the chemotherapy into action. Zhao stated his team zeroed in on metastatic cancer that occurs when the disease moves to additional parts of the body. Metastatic tumors are especially dangerous. They are responsible for90 percent of all cancer deaths.

Why the new Stem Cell Therapy is Important

Zhao is adamant his stem cell therapy represents an important newparadigm in the context of cancer therapy. Indeed, Zhao has blazed a trail in a new direction that others will likely follow in the years to come. It is possible his new stem cell therapy serves as an alternative and more effective means of treating cancer. This stem cell therapy will serve as an alternative to numerous forms of chemotherapy that typically have nasty side effects. Chemotherapy certainly kills plenty of growing cancer cells yet it can also harm healthy cells. The new type of treatment keys in on metastatic tissue that allows for the avoidance of the undesirable side effects produced by chemotherapy.

Though the published piece describing this stem cell therapy is centered on breast cancer metastases within thelungs, the method will soon be applicable to additional metastases. This is due to the fact that numerous solid tumors are stiffer than regular tissue. The new system does not force scientists to invest time and effort to pinpoint and create a brand new protein or genetic marker for each kind of cancer.

The Next Step

At this point in time, Zhao's team has performed pre-clinical animal studies to show the treatment is effective and safe. They plan to segue to human studies in the coming months and years. Zhao's team is currently expanding to additional types of cells such as cancer tissue-sensing and engineered immune system CAR-T (T cells) to treat metastasizing colon and breast cancers. Their goal is totransform this technology for the treatment of additional diseases ranging from diabetes to fibrosis and beyond.

Link:
Stem Cell Therapy Selectively Targets and Kills Cancerous Tissue - Anti Aging News